Croker, Ben A.Kelliher, Michelle A.2022-08-232022-08-232019-01-102019-03-18<p>Blood. 2019 Jan 10;133(2):103-104. doi: 10.1182/blood-2018-11-886242. <a href="https://doi.org/10.1182/blood-2018-11-886242">Link to article on publisher's site</a></p>0006-4971 (Linking)10.1182/blood-2018-11-88624230630845https://hdl.handle.net/20.500.14038/40942In this issue of Blood, Wagner and colleagues implicate Rip1 kinase (Ripk1)–mediated necroptosis in myelodysplastic syndrome (MDS)-like disease in mice and detect increased RIPK1 expression and mixed lineage kinase domain-like pseudokinase (MLKL) activation in human MDS samples.1en-USCell BiologyCellular and Molecular PhysiologyEnzymes and CoenzymesHemic and Immune SystemsHemic and Lymphatic DiseasesBID-ding on necroptosis in MDSJournal Articlehttps://escholarship.umassmed.edu/oapubs/374114048157oapubs/3741